Skip to content

Perineal Massage and Pelvic Floor Exercise in the Antenatal Period

The Effect of Perineal Massage and Pelvic Floor Exercise Applied in the Antenatal Period on Postpartum Sexuality and Incontinence: a Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05624060
Enrollment
75
Registered
2022-11-21
Start date
2023-02-01
Completion date
2023-11-20
Last updated
2025-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fecal Incontinence, Sexual Dysfunction, Sexuality, Urinary Incontinence

Brief summary

This study aimed to determine the effect of perineal massage and pelvic floor exercise in the antenatal period on sexuality and urinary and fecal incontinence in the postpartum period. This study will be conducted in a pregnant school at a state hospital in Turkey. An active control group will be formed as the control group. The control group will be given the Pelvic Floor Dysfunction Prevention Training booklet prepared by the researchers. Experimental 1 group will receive perineal massage training in addition to the Pelvic Floor Dysfunction Prevention Training booklet given to the control group. Experimental 2 group will receive pelvic floor exercises in addition to perineal massage training and the Pelvic Floor Dysfunction Prevention Training booklet given to the control group.

Detailed description

The research was conducted as a randomized controlled trial. The simple randomization method will be used for the assignment to groups. The data of the research; will be collected using the Preliminary Evaluation Form, Personal Information Form, Female Sexual Function Index, The International Consultation on Incontinence Questionnaire-ICIQ-SF (Turkish Version), and Fecal Incontinence Severity Index. The research will start at the 34th week of pregnancy and the questionnaires will be administered in the 3rd month after delivery. There will be 3 groups in the research.An active control group will be formed as the control group. The control group will be given the Pelvic Floor Dysfunction Prevention Training booklet prepared by the researchers. Experimental 1 group will receive perineal massage training in addition to the Pelvic Floor Dysfunction Prevention Training booklet given to the control group. Experimental 2 group will receive pelvic floor exercises in addition to perineal massage training and the Pelvic Floor Dysfunction Prevention Training booklet given to the control group.

Interventions

BEHAVIORALPelvic Floor Dysfunction Prevention Training

The Pelvic Floor Dysfunction Prevention Training booklet is cover weight control, perineal hygiene, adequate fluid consumption, not smoking and alcohol use, avoidance of spicy, fizzy and fatty foods and beverages, correct posture and frequency of micturition, prevention of constipation and abdominal pressure.

BEHAVIORALPelvic Floor Dysfunction Prevention Training and Perineal Massage

Women will apply perineal massage for an average of 8-10 minutes at least twice a week, starting from the 34th week of pregnancy until delivery. In addition to perineal massage, the Pelvic Floor Dysfunction Prevention Training booklet will be given to participant.

BEHAVIORALPelvic Floor Dysfunction Prevention Training and Perineal Massage and Pelvic Floor Exercise

Women assigned to this group will apply pelvic floor exercise at least 3 days a week 8-12 times a week, starting from the 34th week of pregnancy until delivery. In addition, women will apply perineal massage for an average of 8-10 minutes at least twice a week, starting from the 34th week of pregnancy until delivery. In addition to perineal massage, the Pelvic Floor Dysfunction Prevention Training booklet will be given to participant.

Sponsors

Gazi University
CollaboratorOTHER
Bitlis Eren University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* being over 18 years old, * being 32-34th pregnancy weeks, * being not experiencing any complications in the mother and fetus during pregnancy (gestational diabetes, hypertension, preeclampsia, intrauterine growth retardation, congenital anomaly, etc.), * having a singleton pregnancy, * being primiparous * being volunteer to participate in the study

Exclusion criteria

* elective cesarean section planning, * having a history of chronic constipation, * having a previous history of urinary or anal incontinence, * having genital infection with lesions (HSV, HPV, Syphilis, Candida Albicans, Chancroid)

Design outcomes

Primary

MeasureTime frameDescription
Female Sexual Function IndexPostpartum 12th weeksIn the structure of the scale; There are 6 sub-dimensions: desire, arousal, lubrication (lubrication, wetting), orgasm, satisfaction and pain.The highest raw score that can be obtained from the scale is 95 and the lowest raw score is 4.After sub-dimension averages were multiplied by factor loads, the highest score that could be obtained from the scale was calculated as 36 and the lowest score as 2. High score means better function.
The International Consultation on Incontinence Questionnaire-ICIQPostpartum 12th weeksThe International Consultation on Incontinence Questionnaire-ICIQ-SF (Turkish Version) is a scale for evaluating every aspect of urinary incontinence and its impact on quality of life.It consists of 6 questions.The ICIQ Total Score is calculated by the sum of the 3+4+5 questions and scores between 0 and 21. If the score is high and close to 21, it shows that it is overly affected.
Fecal Incontinence Severity Index-FISIPostpartum 12th weeksIt is an index developed to diagnose the frequency and type of fecal incontinence.It defines the type of fecal incontinence in four types and its frequency in five categories. The index score is calculated by summing the numbers corresponding to each box and the patient score. In patient-weighted scoring, the highest score that can be obtained from the index is 61 and the lowest score is 0.The cut-off score of the index is 31.7.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026